hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Lung Cancer
Related studies linked through entity extraction aliases.
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
- Status
- UNKNOWN
- Phase
- NA
Physiotherapy Prehabilitation in Patients Undergoing Cardiac or Thoracic Surgery
- Status
- COMPLETED
- Phase
- NA
Multimodal Prehabilitation to Enhance Functional Recovery After Lung Surgery
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Benefit of a High Frequency Ventilation System During Lung or Breast Cancer Radiotherapy Treatment
- Status
- TERMINATED
- Phase
- NA
Precision Diagnosis and Therapy for Early Stage Lung Cancer
- Status
- UNKNOWN
- Phase
- NA
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated
- Status
- COMPLETED
- Phase
- N/A
An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Integrative Analysis of Large-cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
EBUS-TBNA vs Flex 19G EBUS-TBNA
- Status
- UNKNOWN
- Phase
- NA
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
- Status
- UNKNOWN
- Phase
- N/A
VATS Versus Open Pulmonary Lobectomy in the Limelight of OEP
- Status
- COMPLETED
- Phase
- N/A
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
- Status
- RECRUITING
- Phase
- N/A
Validation of a Kinetic Model of Erlotinib
- Status
- UNKNOWN
- Phase
- N/A
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Early Stage Lung Cancer Screening With Low-dose Computed Tomographic
- Status
- UNKNOWN
- Phase
- NA